Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

464 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Deep whole-genome ctDNA chronology of treatment-resistant prostate cancer.
Herberts C, Annala M, Sipola J, Ng SWS, Chen XE, Nurminen A, Korhonen OV, Munzur AD, Beja K, Schönlau E, Bernales CQ, Ritch E, Bacon JVW, Lack NA, Nykter M, Aggarwal R, Small EJ, Gleave ME; SU2C/PCF West Coast Prostate Cancer Dream Team; Quigley DA, Feng FY, Chi KN, Wyatt AW. Herberts C, et al. Among authors: small ej. Nature. 2022 Aug;608(7921):199-208. doi: 10.1038/s41586-022-04975-9. Epub 2022 Jul 20. Nature. 2022. PMID: 35859180
Hormonal treatment for prostate cancer.
Harris KA, Small EJ. Harris KA, et al. Among authors: small ej. Expert Opin Investig Drugs. 2001 Mar;10(3):493-510. doi: 10.1517/13543784.10.3.493. Expert Opin Investig Drugs. 2001. PMID: 11227048 Review.
Immunotherapy for prostate cancer.
Fong L, Small EJ. Fong L, et al. Among authors: small ej. Curr Oncol Rep. 2007 May;9(3):226-33. doi: 10.1007/s11912-007-0026-z. Curr Oncol Rep. 2007. PMID: 17430695 Review.
Sipuleucel-T for the treatment of prostate cancer.
Harzstark AL, Small EJ. Harzstark AL, et al. Among authors: small ej. Drugs Today (Barc). 2008 Apr;44(4):271-8. doi: 10.1358/dot.2008.44.4.1212301. Drugs Today (Barc). 2008. PMID: 18536785 Review.
Castrate-resistant prostate cancer: therapeutic strategies.
Harzstark AL, Small EJ. Harzstark AL, et al. Among authors: small ej. Expert Opin Pharmacother. 2010 Apr;11(6):937-45. doi: 10.1517/14656561003677382. Expert Opin Pharmacother. 2010. PMID: 20307219 Review.
The effect of prior androgen synthesis inhibition on outcomes of subsequent therapy with docetaxel in patients with metastatic castrate-resistant prostate cancer: results from a retrospective analysis of a randomized phase 3 clinical trial (CALGB 90401) (Alliance).
Aggarwal R, Halabi S, Kelly WK, George D, Mahoney JF, Millard F, Stadler WM, Morris MJ, Kantoff P, Monk JP, Carducci M, Small EJ; Alliance for Clinical Trials in Oncology. Aggarwal R, et al. Among authors: small ej. Cancer. 2013 Oct 15;119(20):3636-43. doi: 10.1002/cncr.28285. Epub 2013 Jul 31. Cancer. 2013. PMID: 23913744 Free PMC article. Clinical Trial.
464 results